Abdominal Imaging

ARRS: MASLD diagnosis may be subject to racial factors
By Kate Madden Yee
The diagnosis of metabolic-associated steatotic liver disease (MASLD) may be influenced by ethnic, racial, and social factors.
April 28, 2025
Liver Disease Stages
Abdominal CT imaging shows potential for diagnosing sarcopenia
By Kate Madden Yee
Abdominal CT imaging shows potential for the opportunistic diagnosis of sarcopenia, enabling radiologists to play a greater role in population health management.
April 18, 2025
Sarcopenia Strips Of Paper
ECR: Use MR enterography for complex IBD cases
By Liz Carey
Four takeaways from an advanced course on imaging inflammatory bowel disease (IBD) cases
February 27, 2025
3 D Illustration Crohn Disease
Soft tissue changes on follow-up CT suggest PDAC recurrence postsurgery
By Kate Madden Yee
CT shows that soft tissue changes after pancreatic ductal adenocarcinoma (PDAC) surgery suggest local recurrence, researchers have reported.
August 23, 2024
Pancreas New
CT-based AI algorithm comparable to rads for identifying renal masses
By Kate Madden Yee
A multiphase CT-based AI algorithm shows comparable performance to radiologists for identifying benign small renal masses.
May 15, 2024
Liver Cancer
CT shows effects of sarcopenia on liver cancer survival
By Kate Madden Yee
CT has revealed that sarcopenia is a prognostic factor for poor overall survival after liver resection for cancer, researchers have reported.
March 22, 2024
Liver Cancer
LI-RADS shows low NPV in per-patient liver tumor assessment
By Amerigo Allegretto
Per-patient grouping for liver tumor status based on LI-RADS and treatment response shows low NPV in detecting residual or untreated tumors.
December 20, 2023
Images in a 55-year-old patient show hepatitis C-related cirrhosis and a transjugular intrahepatic portosystemic shunt (dashed arrow), with an undiagnosed tumor (dashed circle) at pretransplant imaging by both readers. Left: Noncontrast-enhanced axial CT image with a treated observation (dashed circles on the left, middle, and right images) and dense lipiodol staining (arrows) in the anterior right liver. Middle: Late arterial phase CT image with no appreciable enhancement. Right: Delayed phase image with no appreciable washout. The lesion was deemed at explant pathology to have 20% necrosis. Image courtesy of RSNA.
Abdominal fat CT radiomics help predict liver cancer recurrence
By Kate Madden Yee
CT radiomics features identified from abdominal fat and muscle tissue can help predict early recurrence of liver cancer after surgery, researchers have found.
October 31, 2023
Fat Tissue Adipocytes 400
COVID-19 pandemic led to apparent decreases in cancer incidence
By Amerigo Allegretto
The COVID-19 pandemic led to apparent decreases in cancer incidence for several cancer types, suggest Canadian findings published September 5 in JAMA Network Open.
September 5, 2023
2023 09 05 21 24 9441 Covid 19 Second Wave 400
FDOPA-PET/CT predicts survival in patients with midgut NETs
By Will Morton
PET/CT imaging with F-18 fluorodopa (FDOPA) is an effective approach for detecting neuroendocrine tumors (NETs) -- and now the scans may be used to predict survival in patients with tumors in the midgut, according to researchers in France.
September 5, 2023
2023 09 05 17 32 1374 2023 09 05 Pet Ct Midgut Ne Ts 400
CEUS with perfluorobutane improves HCC diagnosis
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) with Kupffer-cell agents has high specificity and sensitivity for diagnosing liver cancer, suggest findings published August 29 in Radiology.
August 28, 2023
2023 08 29 20 27 9331 2023 08 29 Radiology Ceus 20230829205737
DECT improves diagnosis of aggressive liver cancer subtypes
By Kate Madden Yee
With help from AI and radiomics analysis, dual-energy CT (DECT) can be an effective way to diagnose an aggressive macrotrabecular-massive subtype of hepatocellular carcinoma, a research team has found.
August 22, 2023
2018 10 18 23 20 1387 Liver Cancer 400
Page 1 of 84
Next Page